GlaxosmithKline Consumer Nigeria Plc on Tuesday published its First Quarter report for the period ended, 31 March 2021.
The Group reported a turnover of N3.46 billion, down by 30.62% from N4.99 billion reported in Q1 2020.
GSK in Q1 2021 declared a loss of N238.065 million as against the profit of N113.473 million declared in Q1 2020.
Earnings per share in Q1 2021 dropped to -20 kobo from the EPS of 9 kobo reported in Q1 2020.
At the share price of N6.15, the P.E ratio of Glaxosmithkline Consumer Nigeria Plc stands at -30.89x with earnings yield of -3.24%.